Nevertheless, our study is in good agreement with various reports, that show an improved neurological function after experimental stroke in animals treated with complement-inhibitors [33], treated with the complement-depleting agent cobra venom factor [58,9], or in animals which lack complement components, e.g. C3-deficient mice [59]. The gene discussed is C3; the disease is stroke disorder.